GK Pharmaceutical Contract Manufacturing Operations “GK CMO”, is a contract manufacturing Plant performing cGMP contract manufacturing services. These include: aseptic filling of parenteral for Biologics, bio-similars, drug substances, and solid dosage finishes. GK provides Pharmaceutical-product services including stability, preclinical, and clinical studies. GK CMO offers sterile manufacturing services from Phase I through Commercial.
GK CMO will aim to help clients enter the U.S. market by providing the development, manufacturing and regulatory approval services with the Federal Drug Administration (“FDA”) and other regulatory agencies for pharmaceutical companies.
GK CMO just broke ground with its new manufacturing facilities in the summer of 2019, and will be the first and only Pharmaceutical and Biotechnology company in Puerto Rico to have the technology and capacity to manufacture Biologics, Bio-similars, Drug Substances, and Solid Drug products within the same facility.
Mayra L Guzman-Kaslow, president and CEO of GK Pharmaceuticals Contract Manufacturing Operations (GK CMO), the first biopharmaceutical company owned by minority woman in the US, highlights the obstacles she and…
GK CMO, a Puerto Rican contract manufacturing organization (CMO) recently inaugurated its manufacturing facility on the island. With the potential to manufacture advanced biologic and biosimilar products, the event could…
Mr Acar, could you present to our readers the Institution’s historical development and its role today in the Turkish pharmaceutical and healthcare sector? Before Social Security Reform was initiated, there…
We use cookies to ensure that we give you the best experience on our site. For more info